Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martina Incerti
Institutions:
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”,
IRCCS Humanitas Research Hospital
Observed institutions:
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”,
IRCCS Humanitas Research Hospital
ORCID:
0000-0002-4550-0020
Observed ORCID:
0000-0002-4550-0020
OpenAlex ID:
A5113049738
RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
·
Cancer Discovery
·
29
PDF
Heme catabolism and heme oxygenase-1-expressing myeloid cells in pathophysiology
2024
·
Francesca Maria Consonni
, Martina Incerti
, et al.
·
Frontiers in Immunology
·
23
PDF
Myeloid metabolism and its role in immunotherapy of cancer
2025
·
Valentina Garlatti
, Francesca Maria Consonni
, et al.
·
Journal for ImmunoTherapy of Cancer
·
6
PDF
Gasotransmitters bridging tumor biology and immunity: from pathophysiological insights to therapeutic potential
2026
·
Giulia Ballerini
, Andrea Balboni
, et al.
·
Frontiers in Immunology
·
4
PDF
787 RORγ bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Figure S10 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S8 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S3 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S1 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S2 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Data from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
Table S2 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S7 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S5 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S11 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S6 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Table S1 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
Figure S9 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S4 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Table S4 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Table S3 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
Table S5 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Show more works
View as search
Works count:
22
Citation count:
62
H-index:
4
I10-index:
2
Year
Topic
Type